| Literature DB >> 26810226 |
Ana V Miletic1, Julia Jellusova1, Matthew H Cato1, Charlotte R Lee1, Gisele V Baracho1, Edward M Conway2, Robert C Rickert3.
Abstract
Survivin is a member of the inhibitor of apoptosis family of proteins and a biomarker of poor prognosis in aggressive B cell non-Hodgkin's lymphoma. In addition to its role in inhibition of apoptosis, survivin also regulates mitosis. In this article, we show that deletion of survivin during early B cell development results in a complete block at the cycling pre-B stage. In the periphery, B cell homeostasis is not affected, but survivin-deficient B cells are unable to mount humoral responses. Correspondingly, we show that survivin is required for cell division in response to mitogenic stimulation. Thus, survivin is essential for proliferation of B cell progenitors and activated mature B cells, but is dispensable for B cell survival. Moreover, a small-molecule inhibitor of survivin strongly impaired the growth of representative B lymphoma lines in vitro, supporting the validity of survivin as an attractive therapeutic target for high-grade B cell non-Hodgkin's lymphoma.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26810226 PMCID: PMC4761464 DOI: 10.4049/jimmunol.1501690
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422